Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
Line 204: | Line 204: | ||
} | } | ||
.cont p { | .cont p { | ||
- | font-size: | + | font-size:27px; |
- | line-height: | + | line-height:28px; |
width:auto; | width:auto; | ||
height:auto; | height:auto; | ||
Line 261: | Line 261: | ||
<!--<img style="opacity:0.8" src="https://static.igem.org/mediawiki/2013/7/78/PB_ProjectLarge1.jpg" width="535px" height="428px" />--!> | <!--<img style="opacity:0.8" src="https://static.igem.org/mediawiki/2013/7/78/PB_ProjectLarge1.jpg" width="535px" height="428px" />--!> | ||
<div style="position:relative;bottom:0px"> | <div style="position:relative;bottom:0px"> | ||
- | <div class="cont"><p style=" font-size: | + | <div class="cont"><p style=" font-size:32px;line-height:34px;">FIGHT TUBERCULOSIS WITH MODERN WEAPONS </p></div> |
<div class="cont"> | <div class="cont"> | ||
<p> | <p> |
Revision as of 15:20, 29 September 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
An E. coli which invades macrophages and kills mycobacteria.
Our results here